Wednesday, April 8, 2026

Assertio to be acquired by Garda Therapeutics for $18 per share in cash plus contingent value right

 


  • Assertio completed sale of its non-Rolvedon assets to Cosette Pharmaceuticals alongside the Garda Therapeutics agreement announcement.
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.